News & Videos - BIOTECHNOLOGY - English

[NOT FOR DISTRIBUTION TO U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES] CALGARY, AB / ACCESSWIRE / April 26, 2024 / Asia Green Biotechnology Corp. (" Asia Green " or the " Company ") (CSE:ASIA) announces that it will not meet the filing date of April 29, 2024 (" Filing Date "), as required under National Instrument 51-102, for filing of the following continuous disclosure documents (collectively, the " Documents "): The Company's Annual Audited Financial Statements for the year ended...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, AB / ACCESSWIRE / April 17, 2024 / Asia Green Biotechnology Corp. (" Asia Green " or the " Company ") (CSE:ASIA) announces that it is unlikely to meet the filing date of April 29, 2024 (" Filing Date "), as required under National Instrument 51-102, for filing of the following continuous disclosure documents (collectively, the " Documents "): The Company's Annual Audited Financial Statements for the year...

CALGARY, AB / ACCESSWIRE / April 12, 2024 / Asia Green Biotechnology Corp. ("AGB" or the "Company") (CSE:ASIA), announced today that it has changed its auditor from Paul J. Rozek Professional Corporation, Chartered Professional Accountant (the "Former Auditor") to MNP LLP (the "Successor Auditor"), effective April 5, 2024 (the "Effective Date"). At the request of the Company, the Former Auditor resigned as the auditor of the Company and the Board of Directors of the Company appointed the...

EQS-Media / 08.04.2024 / 11:58 CET/CEST Anbio Biotechnology is expanding into the European market with its star product AF-100 C, a ground-breaking compact fluorescent immunoassay analyzer, which is to revolutionize point-of-care testing. With over 70 assays, the AF-100 C aims to empower healthcare providers in the EU, enhancing patient care and prognosis. Frankfurt, Germany – In a strategic move to broaden its presence in the European Union, Anbio Biotechnology (Anbio), a global leader in...

Jamie Metzl, one of the world's leading technology and healthcare futurists, is all set to headline at the Global AI Show, taking place at the Grand Hyatt Dubai on April 16 and 17, 2024. DUBAI, Mar 25, 2024 - (ACN Newswire) - The Global AI Show is thrilled to announce Jamie Metzl, esteemed author, technology visionary, and healthcare futurist, as a featured speaker for its upcoming two-day conference. Set to convene thought leaders and industry experts from across the globe, this event promises...

HONG KONG, Mar 18, 2024 - (ACN Newswire) - Essex Bio-Technology Limited ("Essex" or the "Group", Stock Code: 1061.HK) today announced the annual results for the year ended 31 December 2023. Financial Performance The Group weathered the headwinds and managed to deliver sound performances amidst the challenging trading environment in 2023. During the year under review, the Group achieved a consolidated revenue of approximately HK$1,706.6 million, with an increase of 29.5% as compared to last year,...

CYBER ENVIRO-TECH, INC ACQUIRES STABLEX AND SECURES EXCLUSIVE GLOBAL LICENSES TO INTELLECTUAL PROPERTY RIGHTS FROM KAM BIOTECHNOLOGY LTD. PR Newswire SCOTTSDALE, Ariz., Feb. 27, 2024 SCOTTSDALE, Ariz. , Feb. 27, 2024 /PRNewswire/ -- (OTC Pink: CETI), Cyber Enviro-Tech, Inc. is pleased to announce the acquisition of the patent for Stablex and the geographic expansion of its license rights for seven proprietary intellectual biotechnology compounds of KAM Biotechnology Ltd ("KAM") from the United...

CALGARY, AB / ACCESSWIRE / February 21, 2024 / ASIA GREEN BIOTECHNOLOGY CORP. (CSE:ASIA) (" Asia Green " or the " Company ") is pleased to announce that it has entered into a non-binding letter of intent (" LOI ") to acquire all of the issued and outstanding shares of Burton Growers Ltd. (" Burton Growers ") and Green Sight Agri-Holdings Inc. (" Green Sight "), two private companies active in the Canadian hemp production industry. Burton Growers is the owner of a 25,000 sq. ft. greenhouse and...

Nuvalent to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference PR Newswire CAMBRIDGE, Mass., Feb. 1, 2024 CAMBRIDGE, Mass. , Feb. 1, 2024 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter , Ph.D., Chief Executive Officer, and Alexandra Balcom , Chief Financial Officer, will participate in a...

Sumitomo Corporation makes investment in Brazilian insect protein production and biotechnology company Cyns to Support Next Generation Sustainable Feed Production PR Newswire NEW YORK, Jan. 30, 2024 NEW YORK , Jan. 30, 2024 /PRNewswire/ -- Sumitomo Corporation, through Sumitomo Corporation do Brasil S.A. announced today a joint investment in a Seed round for Cyns, a biotechnology company located in Sao Paulo, Brazil , to unlock the next chapter of black soldier fly (BSF) farming in Latin America...

Thinking about buying stock in Marpai, Phunware, Spirit Airlines, BigBear.ai, or Puma Biotechnology? PR Newswire NEW YORK, Jan. 18, 2024 NEW YORK , Jan. 18, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MRAI, PHUN, SAVE, BBAI, and PBYI. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. MRAI:...

ASCO GI 2024: Golden Biotech's Antroquinonol Shows Significantly Prolonged Survival in Untreated Metastatic Pancreatic Cancer Patients PR Newswire TAIPEI, Jan. 18, 2024 TAIPEI , Jan. 18, 2024 /PRNewswire/ -- Golden Biotechnology Corp. (TPEX 4132) ("GoldenBiotech", GBC), an advanced biopharmaceutical drug development company, had unveiled the findings of its Phase II clinical trial investigating Antroquinonol (HOCENA) in combination with the standard of care (SOC): nab-paclitaxel + gemcitabine,...

Valtech Provides Biotechnology and Technology Startup Orientated Valuation Support PR Newswire HONG KONG, Dec. 7, 2023 HONG KONG , Dec. 7, 2023 /PRNewswire/ -- Valtech Valuation has recently concluded valuations for several projects within the biotechnology and medical technology sector, specifically focusing on genetic engineering. We are honored to have been entrusted with providing valuation opinions to the management of Hong Kong -based and Singapore -based startups seeking private equity...

Valtech Provides Biotechnology and Technology Startup Orientated Valuation Support PR Newswire HONG KONG, Dec. 7, 2023 HONG KONG , Dec. 7, 2023 /PRNewswire/ -- Valtech Valuation has recently concluded valuations for several projects within the biotechnology and medical technology sector, specifically focusing on genetic engineering. We are honored to have been entrusted with providing valuation opinions to the management of Hong Kong -based and Singapore -based startups seeking private equity...

CHICAGO, IL / ACCESSWIRE / November 17, 2023 / More than 300,000 people are diagnosed with brain cancer across the globe each year. Glioblastoma represents the majority of these cases in the U.S., with 15,000 new patients diagnosed and more than 10,000 deaths annually. A potentially revolutionary therapy option could help treat the many individuals who are fighting glioblastoma, the most aggressive and common type of cancer that originates in the brain. Earlier in November, the U.S. Food and...

Danaher appoints Christopher Riley to Executive Vice President for Biotechnology PR Newswire WASHINGTON, Oct. 31, 2023 WASHINGTON , Oct. 31, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), a leading global life sciences and diagnostics innovator, today announced that Christopher Riley has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility for its Biotechnology business, effective January 1, 2024. Mr. Riley,...

New results from a targeted therapy and immuno-oncology company show the promising potential efficacy of one of its first-in-class treatments. CHICAGO, IL / ACCESSWIRE / October 31, 2023 / MAIA Biotechnology Inc. (NYSE:MAIA) is focused on the development and commercialization of drugs that improve and extend the lives of people with cancer. The company's lead program is THIO , an investigational telomere-targeting agent that is currently being developed as a second or later line of treatment for...

iNtRON, Executes Evaluation License and Option Agreement for SAL200 PR Newswire BOSTON and SEOUL, South Korea, Oct. 30, 2023 iNtRON Grants Basilea exclusive right for preclinical evaluation with an undisclosed payment Basilea has the option to enter into exclusive License Agreement following the evaluation BOSTON and SEOUL, South Korea , Oct. 30, 2023 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.intodeworld.com ) has announced today that they have signed an "EVALUATION LICENSE AND OPTION...

Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board PR Newswire SAN JOSE, Calif., Oct. 23, 2023 SAN JOSE, Calif. , Oct. 23, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has appointed Mark A. Goldberg , MD, to its Cancer Business Advisory Board (CBAB). "We are...

CHICAGO, IL / ACCESSWIRE / October 17, 2023 / Diffuse Intrinsic Pontine Glioma (DIPG) is among the most aggressive brain tumors affecting the central nervous system in children. Radiotherapy, the current standard of care, has limitations, including short-lived responses that last about six to nine months on average. Promising new study data shows a potential breakthrough in pediatric brain cancer therapy. Potent Anticancer Activity MAIA Biotechnology Inc. (NYSE:MAIA) is a targeted therapy and...